RADDISH Trademark

Trademark Overview

On Friday, August 4, 2023, a trademark application was filed for RADDISH with the United States Patent and Trademark Office. The USPTO has given the RADDISH trademark a serial number of 98116944. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 15, 2024. This trademark is owned by Global Alzheimer's Platform Foundation Inc.. The RADDISH trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Charitable fundraising; Charitable fundraising for Alzheimer's disease and neurodegenerative disease research and treatment

Promoting public awareness of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registries, patient research, patient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases, and the importance of patient registration on Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease registries; Charitable services, namely, organizing and developing programs that aim to improve the lives of patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Charitable business services, namely, administration of programs for enabling participants to receive services for Alzheimer's, neurodegenerative diseases and other n...

Healthcare services; Healthcare services, namely, administering care to patients; Healthcare services, namely, administering care to patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, administering tests for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, taking samples from patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Establishing tissue, bloods, organ, and stem cell bank of biological samples related to Alzheimer's neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer's, neurodegenerative diseases, and other neurological and central nervous system diseases; Providing health screening services related to Alzheimer's, neurodegenerative disea...

Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases
raddish

General Information

Serial Number98116944
Word MarkRADDISH
Filing DateFriday, August 4, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements

Goods and ServicesCharitable fundraising; Charitable fundraising for Alzheimer's disease and neurodegenerative disease research and treatment
Goods and ServicesPromoting public awareness of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registries, patient research, patient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases, and the importance of patient registration on Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease registries; Charitable services, namely, organizing and developing programs that aim to improve the lives of patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Charitable business services, namely, administration of programs for enabling participants to receive services for Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Business services, namely, recruitment of participants for neuroscience clinical research; Maintaining a registry of participants for neuroscience clinical research relating to the treatment and prevention of brain disease; Promoting participation in clinical trials and research in the neuroscience field; Recruitment advertising services, namely, advertising clinical trials for the purpose of recruiting patients and placing patients for participation in clinical trials in the neuroscience field
Goods and ServicesHealthcare services; Healthcare services, namely, administering care to patients; Healthcare services, namely, administering care to patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, administering tests for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, taking samples from patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Establishing tissue, bloods, organ, and stem cell bank of biological samples related to Alzheimer's neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer's, neurodegenerative diseases, and other neurological and central nervous system diseases; Providing health screening services related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases
Goods and ServicesScientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, September 3, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, July 8, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 8, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 8, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobal Alzheimer's Platform Foundation Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20005
Party NameGlobal Alzheimer's Platform Foundation Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20005

Trademark Events

Event DateEvent Description
Tuesday, August 8, 2023NEW APPLICATION ENTERED
Sunday, September 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 5, 2024ASSIGNED TO EXAMINER
Monday, July 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 8, 2024NON-FINAL ACTION WRITTEN
Monday, April 8, 2024NON-FINAL ACTION E-MAILED
Monday, April 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, July 16, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, July 16, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 16, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

raddish diseases alzheimer neurodegenerative other nervous system central neurological services patients